Skip to main content

Table 2 Distribution of breast cancer subtypes in different subgroups

From: A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

Subgroup Subtype N Percentage (%) Fisher’s exact test (Pvalue) Odds ratio (OR) 95% confidence interval (95% CI)
G1 Luminal A 85 96.5 4.90E-11 14.3244 4.4797 - 45.8043
  Luminal B 1 1.1 0.0143 0.1324 0.0181 - 0.9693
  HER2 type 1 1.1 0.0329 0.1574 0.0214 - 1.1559
  TNBC 1 1.1 1.12E-06 0.0497 0.0069 - 0.3602
G2 Luminal A 192 62.5 3.88E-04 0.5614 0.4105 - 0.7678
  Luminal B 30 9.8 0.0315 1.8715 1.0778 - 3.2496
  HER2 type 22 7.2 0.3592 1.3339 0.7378 - 2.4115
  TNBC 63 20.5 0.0234 1.5571 1.0631 - 2.2806
G3 Luminal A 144 63.7 0.0195 0.6664 0.4788 - 0.9275
  Luminal B 16 7.1 0.6541 0.844 0.461 - 1.5453
  HER2 type 17 7.5 0.6311 1.1713 0.6317 - 2.1719
  TNBC 49 21.7 0.1185 1.3737 0.9225 - 2.0456
G4 Luminal A 113 79 0.0085 1.7894 1.1567 - 2.7682
  Luminal B 8 5.6 0.4771 0.7237 0.3342 - 1.5673
  HER2 type 7 4.9 0.5674 0.7476 0.3278 - 1.705
  TNBC 15 10.5 0.0255 0.5268 0.2972 - 0.9338
  1. CI: confidence interval; HER2: human epidermal growth factor receptor 2; TNBC: triple-negative breast cancer.